Page last updated: 2024-10-26

felodipine and Adenocarcinoma

felodipine has been researched along with Adenocarcinoma in 1 studies

Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kraus-Berthier, L1
Guilbaud, N1
Peglion, JL1
Leonce, S1
Lombet, A1
Pierre, A1
Atassi, G1

Other Studies

1 other study available for felodipine and Adenocarcinoma

ArticleYear
In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Calcium Channels; Colonic N

1994